Mobivity (MFON) 10-K 31 Mar 23 2022 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 30, 2023	Jun. 30, 2022
Document Information [Line Items]
Entity Central Index Key	0001447380
Entity Registrant Name	MOBIVITY HOLDINGS CORP.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	000-53851
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-3439095
Entity Address, Address Line One	3133 West Frye Road, # 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	877
Local Phone Number	282-7660
Title of 12(g) Security	Common Stock, $.001 par value
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 70,218,462
Entity Common Stock, Shares Outstanding		65,607,411
Auditor Name	M&K CPAS, PLLC
Auditor Firm ID	2738
Auditor Location	Houston, TX

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 426,740	$ 735,424
Accounts receivable, net of allowance for doubtful accounts of $34,446 and $56,340, respectively	1,081,183	578,303
Other current assets	195,017	227,458
Total current assets	1,702,940	1,541,185
Goodwill	0	411,183
Right to use lease assets	981,896	1,187,537
Intangible assets and software development costs, net	194,772	1,124,720
Other assets	137,917	173,325
TOTAL ASSETS	3,017,525	4,437,950
Current liabilities
Accounts payable	3,412,612	3,823,909
Accrued interest	443,448	172,239
Accrued and deferred personnel compensation	569,347	495,533
Deferred revenue and customer deposits	902,727	377,170
Related party notes payable, net - current maturities	2,711,171	819,531
Notes payable, net - current maturities	32,617	69,052
Operating lease liability, current	251,665	229,240
Other current liabilities	49,541	9,071
Total current liabilities	8,373,128	5,995,745
Non-current liabilities
Related party notes payable, net - long-term	2,481,290	2,498,711
Notes payable, net - long-term	31,092	39,086
Operating lease liability, noncurrent	936,924	1,188,589
Total non-current liabilities	3,449,306	3,726,386
Total liabilities	11,822,434	9,722,131
Commitments and Contingencies (See Note 13)
Stockholders' equity (deficit)
Common stock, $0.001 par value; 100,000,000 shares authorized; 61,311,155 and 55,410,695, shares issued and outstanding	61,311	55,411
Equity payable	324,799	100,862
Additional paid-in capital	108,806,353	102,446,921
Accumulated other comprehensive income (loss)	(100,963)	(52,088)
Accumulated deficit	(117,896,409)	(107,835,287)
Total stockholders' equity (deficit)	(8,804,909)	(5,284,181)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 3,017,525	$ 4,437,950

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Accounts receivable, allowance for doubtful accounts	$ 34,446	$ 56,340
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	61,311,155	55,410,695
Common stock, shares outstanding (in shares)	61,311,115	55,410,695

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenues
Revenues	$ 7,533,912	$ 8,174,884
Cost of revenues	5,328,483	4,302,370
Gross profit	2,205,429	3,872,514
Operating expenses
Bad Debt	40,383	774,312
General and administrative	4,306,929	3,584,721
Sales and marketing	2,616,596	4,002,565
Engineering, research, and development	3,060,029	3,583,773
Goodwill Impairment	411,183	85,169
Intangible asset impairment	552,476	8,286
Depreciation and amortization	440,326	707,073
Total operating expenses	11,427,922	12,745,899
Loss from operations	(9,222,493)	(8,873,385)
Other income/(expense)
Interest income	0	5
Gain on Extinguishment of Debt	0	891,103
Interest expense	(737,745)	(267,966)
Loss on disposal of fixed assets	0	(880)
Settlement Losses	(53,500)
Loss on settlement of debt	(49,503)	0
Foreign currency gain (loss)	2,119	(8,661)
Total other income (expense)	(838,629)	613,601
Loss before income taxes	(10,061,122)	(8,259,784)
Income tax expense	0	0
Net Loss	(10,061,122)	(8,259,784)
Other comprehensive income (loss), net of income tax
Foreign currency translation adjustments	(48,875)	(28,642)
Comprehensive loss	$ (10,109,997)	$ (8,288,426)
Net loss per share:
Basic and Diluted (in dollars per share)	$ (0.17)	$ (0.15)
Weighted average number of shares:
Basic and Diluted (in shares)	59,241,798	55,410,695

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2020	55,410,695
Balance at Dec. 31, 2020	$ 55,411	$ 100,862	$ 101,186,889	$ (23,446)	$ (99,575,503)	$ 1,744,213
Issuance of common stock	0	0	0	0	0	0
Fair value of options issued with related party debt	0	0	262,758	0	0	262,758
Stock based compensation	0	0	997,274	0	0	997,274
Foreign currency translation adjustments	0	0	0	(28,642)	0	(28,642)
Net loss	$ 0	0	0	0	(8,259,784)	(8,259,784)
Balance (in shares) at Dec. 31, 2021	55,410,695
Balance at Dec. 31, 2021	$ 55,411	100,862	102,446,921	(52,088)	(107,835,287)	(5,284,181)
Issuance of common stock	2,562		2,047,438			2,050,000
Fair value of options issued with related party debt	0	0	143,039	0	0	143,039
Stock based compensation	0	0	1,457,570	0	0	1,457,570
Foreign currency translation adjustments	0	0	0	(48,875)	0	(48,875)
Net loss	$ 0	0	0	0	(10,061,122)	(10,061,122)
Issuance of common stock for warrants exercised (in shares)	3,188,190
Issuance of common stock for warrants exercised	$ 3,188	0	2,547,364	0	0	2,550,552
Issuance of common stock (in shares)	2,562,500
Issuance of common stock for debt settlement (in shares)	149,770
Issuance of common stock for debt settlement	$ 150	223,937	164,021			388,108
Balance (in shares) at Dec. 31, 2022	61,311,155
Balance at Dec. 31, 2022	$ 61,311	$ 324,799	$ 108,806,353	$ (100,963)	$ (117,896,409)	$ (8,804,909)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES
Net loss	$ (10,061,122)	$ (8,259,784)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad Debt	40,383	774,312
Loss on settlement of debt -Related Party	49,503	0
Gain on Extinguishment of Debt	0	(891,103)
Stock-based compensation	1,457,570	997,274
Loss on disposal of fixed assets	0	880
Intangible asset impairment	552,476	8,286
Goodwill Impairment	411,183	85,169
Depreciation and amortization expense	440,326	707,073
Amortization of debt discount	122,258	31,000
Increase (decrease) in cash resulting from changes in:
Accounts receivable	(543,263)	(365,213)
Other current assets	32,102	40,133
Operating lease assets/liabilities	(23,599)	(2,575)
Contracts receivable, long-term	0	707,928
Other assets	(31)	2,330
Accounts payable	(411,297)	1,888,498
Accrued interest	609,814	168,673
Accrued and deferred personnel compensation	(79,283)	270,590
Accrued Professional Fees	148,402	0
Other liabilities - non-current	0	(415,766)
Other liabilities - current	40,470	(2,876)
Deferred revenue and customer deposits	525,557	(229,427)
Net cash used in operating activities	(6,688,551)	(4,484,598)
INVESTING ACTIVITIES
Purchases of equipment	(17,182)	(79,219)
Cash paid for patents	0	0
Capitalized software development costs	(13,087)	(299,253)
Net cash used in investing activities	(30,269)	(378,472)
FINANCING ACTIVITIES
Payments on notes payable	(39,142)	(561,528)
Payments on related party notes payable	0	(280,000)
Proceeds from related party notes payable	1,895,000	3,206,250
Proceeds from conversion of common stock warrants	2,550,552	0
Proceeds from PIPE funding	2,050,000	0
Net cash provided by financing activities	6,456,410	2,364,722
Effect of foreign currency translation on cash flow	(46,274)	(49,048)
Net change in cash	(308,684)	(2,547,396)
Cash at beginning of period	735,424	3,282,820
Cash at end of period	426,740	735,424
Supplemental disclosures:
Interest	0	68,389
Non cash investing and financing activities:
Fair Value of options Issued with related party debt	143,039	0
Debt Discount on Related Party Debt	262,658	262,658
Fixed Assets contribution by lessor	0	110,000
Refinancing of debt-related party	0	43,750
Initial ROU and asset lease liabiltiy	0	1,458,527
Shares Issued for settlement of debt - related party	$ 338,605	$ 0

Note 1 - Nature of Operations

Note 1 - Nature of Operations	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Nature of Operations [Text Block]	1. Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns. Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: ● Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence. ● Measure, predict, and boost guest frequency and spend by channel. ● Deploy and manage one ● Deliver 1:1 Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A, Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 two 2003. 90% two one The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands. Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. ten incremental We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, LiveLenz Inc. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may not Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2022 2021 From time to time, we may one As of December 31, 2022 four December 31, 2021 three Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first not not may We conducted our annual impairment tests of goodwill as of December 31, 2022 2021 December 31, 2022 2021, Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one twenty No may not The Company’s evaluation of its long-lived assets resulted in $552,476 and $8,286 of intangible impairment expense during the years ended December 31, 2022 December 31, 2021 Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985 20” not not Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2022 December 31, 2021 Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830 10, 830 10” Derivative Financial Instruments We do not We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, no During the years ended December 31, 2022 2021 two Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve December 31, 2022 2021 $10,109,997,and Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $377,201 and $962,049 for years ended December 31, 2022 2021 December 31, 2022 2021 Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not not not Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2022 2021 December 31, 2022 2021 Outstanding employee options 6,691,216 6,246,466 Outstanding restricted stock units 1,929,933 1,685,141 Outstanding warrants 6,147,898 3,246,690 14,769,047 11,178,297 Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may In August 2020, 2020 06, 2020 06” No. 2020 06 January 1, 2022.

Note 3 - Going Concern

Note 3 - Going Concern	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	3. We have $426,740 of cash as of December 31, 2022 2022 February 2022 2022. first 2023. 12 no not 12 As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $117,896,409 as of December 31, 2022 twelve not

Note 4 - Goodwill and Intangibl

Note 4 - Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	4. Goodwill and Intangible Assets Goodwill The following table presents goodwill and impairment for the years ended December 31, 2022 2021 Goodwill December 31, 2020 $ 496,352 Acquired — Impairment (85,169 ) December 31, 2021 411,183 Acquired — Impairment (411,183 ) December 31, 2022 $ — We conducted our annual impairment test of goodwill as of December 31, 2022 2021 Intangible assets The following table presents components of identifiable intangible assets for the years ended December 31, 2022 2021 December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Patents and trademarks $ 57,595 $ (4,897 ) $ 52,698 14 $ 105,543 $ (47,948 ) $ 57,595 14 Customer and merchant relationships 545,533 (514,843 ) 30,690 10 2,321,112 (1,775,579 ) 545,533 10 Trade name 32,393 (24,343 ) 8,050 10 197,955 (165,562 ) 32,393 10 Acquired technology 112,191 (112,191 ) — 10 621,030 (508,839 ) 112,191 10 Non-compete agreement 29,212 (29,212 ) — 2 79,300 (50,088 ) 29,212 2 $ 776,924 $ (685,486 ) $ 91,438 $ 3,324,940 $ (2,548,016 ) $ 776,924 During the years ended December 31, 2022 2021 During the years ended December 31, 2022 2021 Expected future intangible asset amortization as of December 31, 2022 Year ending December 31, Amount 2022 $ 35,885 2023 12,639 2024 4,891 2025 4,891 2025 4,891 Thereafter 28,241 Total $ 91,438

Note 5 - Software Development C

Note 5 - Software Development Costs	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	5. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The balance is included in the net intangible assets on the balance sheet. The following table presents details of our software development costs for the years ended December 31, 2022 2021 December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) $ 2,578,611 $ (2,475,277 ) $ 103,334 2 $ 2,565,525 $ (2,217,729 ) $ 347,796 2 $ 2,578,611 $ (2,475,277 ) $ 103,334 $ 2,565,525 $ (2,217,729 ) $ 347,796 Software development costs are being amortized on a straight-line basis over their estimated useful life of two During the years ended December 31, 2022 2021 During the years ended December 31, 2022 2021 The estimated future amortization expense of software development costs as of December 31, 2022 Year ending December 31, Amount 2023 98,828 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 103,334

Note 6 - Operating Lease Assets

Note 6 - Operating Lease Assets	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	6. Operating Lease Assets Adoption of Accounting Standards Codification ( ASC ) Topic 842, Leases." 842 January 1, 2019, January 1, 2019, 842, not The following are additional details related to leases recorded on our balance sheet as of December 31, 2021 Leases Classification Balance at December 31, 2022 Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets 981,896 Total lease assets $ 981,896 Liabilities Current Operating lease liabilities Operating lease liabilities $ 251,665 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 936,924 Total lease liabilities $ 1,188,589 During the year ended December 31, 2022 December 31, 2021 Rent expense was $371,213 and $258,368 for the years ended December 31, 2022 2021 We entered into our current lease starting in February 2021 3133 215, first twelve 50% 842. The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2023 $ 324,221 2024 330,894 2025 337,568 2026 344,241 2027 28,733 Thereafter — Total future lease payments 1,365,657 Less: imputed interest (177,068 ) Total $ 1,188,589 Weighted Average Remaining Lease Term (years) Operating leases 4.08 Weighted Average Discount Rate Operating leases 6.75 %

Note 7 - Notes Payable and Inte

Note 7 - Notes Payable and Interest Expense	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	7. Notes Payable and Related Party Notes Payable The following table presents details of our notes payable as of December 31, 2022 2021 Facility Maturity Interest Rate December 31, 2022 December 31, 2021 ACOA Note February 1, 2024 — 34,231 76,642 TD Bank December 31, 2022 — 29,478 31,496 Related Party Notes various 15 % 5,192,461 3,318,242 Total Debt 5,256,170 3,426,380 Less current portion (2,743,788 ) (888,583 ) Long-term debt, net of current portion $ 2,512,382 $ 2,537,797 Principal payments on notes payables are due as follows: Year ending December 31, Amount 2023 $ 2,743,788 2024 2,497,643 2025 14,739 2026 — 2027 — Thereafter — Total future debt payments 5,256,170 ACOA Note On November 6, 2017, December 2, 2014 June 1, 2016, February 1, 2024. November 1, 2019, August 1, 2021, August 1, 2022 twelve December 31, 2021 19. During the twelve December 31, 2022 Wintrust Loan On November 14, 2018, three first six May 1, 2019, On August 7, 2020, March 31, 2020 June 30, 2020 no twelve December 31, 2021 June 30, 2021. Chase Loan On April 10, 2020, two one six no may July 21, 2021, TD Bank Loan On April 22, 2020, December 31, 2022. zero no December 31, 2023. thirty-three sixty-seven Related Party Notes Secured Promissory Notes On June 30, 2021, one November 11, 2022. December 31, 2021, 2020 The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen may twenty three Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, June 30, 2024. November 11, 2022, 2.3 24 January 31, 2023 not fifteen 365 July 1, 2022, December 31, 2022, On June 10, 2022, On August 09, 2022 On November 22, 2022 On November 30, 2022 On December 27, 2022 During the year ended December 31, 2022 December 31,2022. As of December 31, 2022, $44,325. Unsecured Promissory Note On July 1, 2021, fifteen no December 31, 2023. may two On August 13, 2022, January 31, 2022, July 1, 2022 December 31, 2022 As of December 31, 2022, $10,423 Interest Expense The following table summarizes interest expense for the years ended December 31, 2022 2021 December 31, 2022 2021 Interest expense $ 737,745 $ 267,966 Total interest expense $ 737,745 $ 267,966

Note 8 - Common Stock and Equit

Note 8 - Common Stock and Equity Payable	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Common Stock and Equity Payable	8. Common Stock and Equity Payable Common Stock 2022 On December 31, 2022 $260,010 As of December 31, 2022 $324,799. During the year ended December 31, 2022 5,900,460 $260,010 $0 2021 During the year ended December 31, 2021 not As of December 31, 2022

Note 9 - Stock-based Plans and

Note 9 - Stock-based Plans and Stock-based Compensation	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	9. Stock-based Plans and Stock-based Compensation Stock-based Plans We have the 2010 2013 2016 2022 December 31, 2022 We believe that such awards better align the interests of our directors, officers and employees with those of our shareholders. Option awards are generally granted with an exercise price that equals the fair market value of our stock at the date of grant. These option awards generally vest based on four The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2022 2021 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 527,868 Granted 637,500 $ 1.56 — $ — Exercised — $ 1.61 — $ — Forfeit/canceled (272,029 ) $ 2.18 — $ — Expired (126,557 ) $ 1.17 — $ — Outstanding at December 31, 2021 6,246,466 $ 1.20 7.17 $ 4,056,639 Granted 1,375,000 $ 1.02 — $ — Exercised — $ — — $ — Forfeit/canceled (330,623 ) $ 1.09 — $ — Expired (599,627 ) $ 0.98 — $ — Outstanding at December 31, 2022 6,691,216 $ 1.19 5.86 $ 2,086,829 Expected to vest at December 31, 2022 6,691,216 $ 1.19 5.85 $ 2,086,829 Exercisable at December 31, 2022 3,987,966 $ 1.22 3.98 $ 1,314,652 Unrecognized expense at December 31, 2022 $ 1,698,126 The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At December 31, 2022 The weighted average grant-date fair value of options granted during the years 2022 2021 2021 On March 26, 2021, five March 26, 2021, forty-eight March 26, 2031. On May 17, 2021, one May 17, 2021, forty-eight January 21, 2031. On August 11, 2021, one August 11, 2021, forty-eight August 11, 2031. On December 15, 2021, nineteen December 15, 2021, forty-eight February 18, 2029. $.97 In the twelve December 31, 2021 2022 On March 29, 2022, March 29, 2022, first March 29, 2032. On May 16, 2022, May 16, 2022, first May 16, 2032. On September 22, 2022, September 2022, first September 29, 2032. On December 14, 2022, December 14, 2022, first September 29, 2032. In the twelve December 31, 2022, In the twelve December 31, 2022 $260,010 Stock-based Compensation Expense The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2022 2021 Years Ended December 31, 2022 2021 General and administrative $ 262,060 $ 289,782 Sales and marketing 113,838 81,093 Engineering, research, and development 211,712 178,893 $ 587,610 $ 549,768 As of December 31, 2022 2022 2026. may Stock Option Valuation Assumptions We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2022 2021 Years Ended December 31, 2022 2021 Risk-free interest rate 0.25% to 0.38% 0.42% to 0.58% Expected life (years) 7.00 6.00 Expected dividend yield — — Expected volatility 72.337% to 76.15% 77.36% to 78.21% The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards. The dividend yield assumption is based on our history of not no The expected volatility in 2022 2021 Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2022 2021 Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,120,404 Awarded 654,663 $ 1.77 — $ 60,003 Released — $ — — $ — Canceled/forfeited/expired (406,250 ) $ 1.80 — $ — Outstanding at December 31, 2021 1,685,141 $ 1.18 — $ 1,180,407 Awarded 244,792 $ 1.06 — $ 260,579 Released — $ — — $ — Canceled/forfeited/expired — $ — — $ — Outstanding at December 31, 2022 1,929,933 $ 0.75 — $ 1,440,986 Vested at December 31, 2022 1,929,933 $ — — $ 1,865,401 Unvested at December 31, 2022 — $ — — $ — Unrecognized expense at December 31, 2022 $ — 2021 On March 26, 2021 1/48 th four 2022 On March 26, 2021 four first 2021. March 26, 2024, On May 12, 2021, four May 12, 2024, ( On August 11, 2021, four August 11, 2024, On December 15, 2021, four December 15, 2024, In the twelve December 31, 2021 2022 On March 29, 2022, March 29, 2025, On May 16, 2022, May 16, 2025 ( On September 30, 2022, $.9985 September 30, 2025 ( On December 31, 2022 December 31, 2025, In the twelve December 31, 2022 Restricted Stock Unit Compensation Expense The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2022 2021 Years Ended December 31, 2022 2021 General and administrative $ 260,010 $ 260,005 Sales and Marketing — 187,501 $ 260,010 $ 447,506

Note 10 - Warrants to Purchase

Note 10 - Warrants to Purchase Common Stock	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Warrants To Purchase Common Stock Disclosure [Text Block]	10. Warrants to Purchase Common Stock The following table summarizes investor warrant activity as of and for the years ended December 31, 2022 2021 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 Granted 580,231 $ — — Exercised — $ — — Canceled/forfeited/expired (25,000 ) $ — — Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised — $ — — Canceled/forfeited/expired (3,188,190 ) $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 We did record stock-based compensation expense of $609,950 December 31, 2022 2021 Warrants Exercised in 2021 On June 30, 2021, On August 11, 2021, 30 As of September 30, 2021, 2023. 2024. Warrants Exercised in 2022 On February 9, 2022, three February 2025. February 9, 2022. On June 29, 2022, six three June 2025, On August 24, 2022, five three August 2025,

Note 11 - Income Taxes

Note 11 - Income Taxes	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	11. Income Taxes On March 27, 2020, 19 2017 2017 1 2019 2020; 2 3 4 5 not For the years ended December 31, 2022 2021 2022 2021 Federal – current $ — $ — State – current — — Foreign – current — — Total $ — $ — Under ASC 740, Significant components of our net deferred tax assets and liabilities as of December 31, 2022 2021 2022 2021 Deferred tax assets (liabilities): Net operating loss carryforwards $ 19,791,000 $ 16,915,000 Stock based compensation 4,781,000 4,372,000 Accrued compensation 231,300 31,000 Depreciation and amortization 3,305,000 3,783,000 Other — 2,000 Total deferred tax assets 28,108,300 25,103,000 Valuation allowance for net deferred tax assets (28,108,300 ) (25,103,000 ) Total $ — $ — The Company has provided a valuation allowance against deferred tax assets recorded as of December 31, 2022 2021 The net change in the total valuation allowance for the year ended December 31, 2022 December 31, 2021 not not not not no As of December 31, 2022 2026. 2028. The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2022 2021 2022 2021 Computed expected tax expense $ (2,088,000 ) $ (1,735,000 ) State taxes, net of federal benefit (1,030,000 ) (799,000 ) Expiration of NOL carryforwards (684,000 ) 87,000 Other 101,000 142,000 Change in valuation allowance 3,701,000 1,729,000 Total $ ---- $ The Company has determined that during 2010 382 2010 2010 not 382, 2010, 382. may The Company files income tax returns in the U.S. federal jurisdiction, Arizona, and California. Because the Company is carrying forward federal and state net operating losses from 2006, 2006. not December 31, 2022

Note 12 - Fair Value Measuremen

Note 12 - Fair Value Measurements of Financial Instruments	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	12. Fair Value Measurements of Financial Instruments The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ — The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,124,720 $ — The Company recorded goodwill, intangible assets and an earn-out payable as a result its business combinations, and these assets were valued with the assistance of a valuation consultant and consisted of Level 3 The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None

Note 13 - Commitments and Conti

Note 13 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	13. Commitments and Contingencies Litigation As of the date of this report, the company has one §501.059 one not not No During the year ending December 31, 2022 three Operating Lease The Company had a lease through January 2021 55 310, December 31, 2022, 842. We have entered into a new lease starting in February 2021 3133 215, first twelve December 31, 2022 842. The Company also had a lease through April 2022 December 31, 2022 842.

Note 14 - Employee Benefit Plan

Note 14 - Employee Benefit Plan	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Compensation and Employee Benefit Plans [Text Block]	14. Employee Benefit Plan The Company has an employee savings plan (the “Plan”) pursuant to Section 401 may not may December 31, 2022 2021

Note 15 - Related Party Transac

Note 15 - Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	15. Related Party Transactions Related Party Notes Secured Promissory Notes On June 30, 2021, one November 11, 2022. December 31, 2021, 2020 The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen may twenty three Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, June 30, 2024. November 11, 2022, 2.3 24 January 31, 2023 not fifteen 365 July 1, 2022, December 31, 2022, On June 10, 2022, On August 09, 2022 On November 22, 2022 On November 30, 2022 On December 27, 2022 During the year ended December 31, 2022 December 31,2022. As of December 31, 2022, $44,325 Unsecured Promissory Note On July 1, 2021, fifteen no December 31, 2023. may two On August 13, 2022, January 31, 2022, July 1, 2022 December 31, 2022 As of December 31, 2022, $10,423 Related Party Warrant Exercise On February 7, 2022, $1.283,518. three February 2025. On February 7, 2022, three February 2025. Related Party Private Placement On August 24, 2022, three August 2025.

Note 16 - Subsequent Events

Note 16 - Subsequent Events	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	16. Subsequent Events 2023 During the quarter ended March 30, 2023, 15 three February 2025. 2023 On January 31, 2023, No. 1 November 11, 2022, December 1, 2025. January 1, 2024 December 1, 2025, ninety 90 The foregoing description of the Amendment does not 8 January 31, 2023, 10.1 8 2023 On January 31, 2023 On March 27, 2023 On March 27, 2023

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, LiveLenz Inc. All significant intercompany balances and transactions have been eliminated.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may
Reclassification, Comparability Adjustment [Policy Text Block]	Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no
Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]	Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may not
Receivable [Policy Text Block]	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2022 2021 From time to time, we may one As of December 31, 2022 four December 31, 2021 three
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first not not may We conducted our annual impairment tests of goodwill as of December 31, 2022 2021 December 31, 2022 2021, Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one twenty No may not The Company’s evaluation of its long-lived assets resulted in $552,476 and $8,286 of intangible impairment expense during the years ended December 31, 2022 December 31, 2021
Internal Use Software, Policy [Policy Text Block]	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985 20” not not Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2022 December 31, 2021
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830 10, 830 10”
Derivatives, Reporting of Derivative Activity [Policy Text Block]	Derivative Financial Instruments We do not We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one
Revenue [Policy Text Block]	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, no During the years ended December 31, 2022 2021 two
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve December 31, 2022 2021 $10,109,997,and
Share-Based Payment Arrangement [Policy Text Block]	Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Cost [Policy Text Block]	Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $377,201 and $962,049 for years ended December 31, 2022 2021 December 31, 2022 2021
Income Tax, Policy [Policy Text Block]	Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not not not
Earnings Per Share, Policy [Policy Text Block]	Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2022 2021 December 31, 2022 2021 Outstanding employee options 6,691,216 6,246,466 Outstanding restricted stock units 1,929,933 1,685,141 Outstanding warrants 6,147,898 3,246,690 14,769,047 11,178,297
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may In August 2020, 2020 06, 2020 06” No. 2020 06 January 1, 2022.

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	December 31, 2022 2021 Outstanding employee options 6,691,216 6,246,466 Outstanding restricted stock units 1,929,933 1,685,141 Outstanding warrants 6,147,898 3,246,690 14,769,047 11,178,297

Note 4 - Goodwill and Intangi_2

Note 4 - Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Goodwill [Table Text Block]	Goodwill December 31, 2020 $ 496,352 Acquired — Impairment (85,169 ) December 31, 2021 411,183 Acquired — Impairment (411,183 ) December 31, 2022 $ —
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Patents and trademarks $ 57,595 $ (4,897 ) $ 52,698 14 $ 105,543 $ (47,948 ) $ 57,595 14 Customer and merchant relationships 545,533 (514,843 ) 30,690 10 2,321,112 (1,775,579 ) 545,533 10 Trade name 32,393 (24,343 ) 8,050 10 197,955 (165,562 ) 32,393 10 Acquired technology 112,191 (112,191 ) — 10 621,030 (508,839 ) 112,191 10 Non-compete agreement 29,212 (29,212 ) — 2 79,300 (50,088 ) 29,212 2 $ 776,924 $ (685,486 ) $ 91,438 $ 3,324,940 $ (2,548,016 ) $ 776,924
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year ending December 31, Amount 2022 $ 35,885 2023 12,639 2024 4,891 2025 4,891 2025 4,891 Thereafter 28,241 Total $ 91,438

Note 5 - Software Development_2

Note 5 - Software Development Costs (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Research Development And Computer Software Disclosure [Table Text Block]	December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) $ 2,578,611 $ (2,475,277 ) $ 103,334 2 $ 2,565,525 $ (2,217,729 ) $ 347,796 2 $ 2,578,611 $ (2,475,277 ) $ 103,334 $ 2,565,525 $ (2,217,729 ) $ 347,796
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year ending December 31, Amount 2022 $ 35,885 2023 12,639 2024 4,891 2025 4,891 2025 4,891 Thereafter 28,241 Total $ 91,438
Computer Software, Intangible Asset [Member]
Notes Tables
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year ending December 31, Amount 2023 98,828 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 103,334

Note 6 - Operating Lease Asse_2

Note 6 - Operating Lease Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Additional Details Related To Leases On Balance Sheet [Table Text Block]	Leases Classification Balance at December 31, 2022 Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets 981,896 Total lease assets $ 981,896 Liabilities Current Operating lease liabilities Operating lease liabilities $ 251,665 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 936,924 Total lease liabilities $ 1,188,589
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Year ending December 31, Amount 2023 $ 324,221 2024 330,894 2025 337,568 2026 344,241 2027 28,733 Thereafter — Total future lease payments 1,365,657 Less: imputed interest (177,068 ) Total $ 1,188,589
Lease, Cost [Table Text Block]	Weighted Average Remaining Lease Term (years) Operating leases 4.08 Weighted Average Discount Rate Operating leases 6.75 %

Note 7 - Notes Payable and In_2

Note 7 - Notes Payable and Interest Expense (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Debt [Table Text Block]	Facility Maturity Interest Rate December 31, 2022 December 31, 2021 ACOA Note February 1, 2024 — 34,231 76,642 TD Bank December 31, 2022 — 29,478 31,496 Related Party Notes various 15 % 5,192,461 3,318,242 Total Debt 5,256,170 3,426,380 Less current portion (2,743,788 ) (888,583 ) Long-term debt, net of current portion $ 2,512,382 $ 2,537,797
Schedule of Maturities of Long-Term Debt [Table Text Block]	Year ending December 31, Amount 2023 $ 2,743,788 2024 2,497,643 2025 14,739 2026 — 2027 — Thereafter — Total future debt payments 5,256,170
Summary Of Interest Expense [Table Text Block]	December 31, 2022 2021 Interest expense $ 737,745 $ 267,966 Total interest expense $ 737,745 $ 267,966

Note 9 - Stock-based Plans an_2

Note 9 - Stock-based Plans and Stock-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 527,868 Granted 637,500 $ 1.56 — $ — Exercised — $ 1.61 — $ — Forfeit/canceled (272,029 ) $ 2.18 — $ — Expired (126,557 ) $ 1.17 — $ — Outstanding at December 31, 2021 6,246,466 $ 1.20 7.17 $ 4,056,639 Granted 1,375,000 $ 1.02 — $ — Exercised — $ — — $ — Forfeit/canceled (330,623 ) $ 1.09 — $ — Expired (599,627 ) $ 0.98 — $ — Outstanding at December 31, 2022 6,691,216 $ 1.19 5.86 $ 2,086,829 Expected to vest at December 31, 2022 6,691,216 $ 1.19 5.85 $ 2,086,829 Exercisable at December 31, 2022 3,987,966 $ 1.22 3.98 $ 1,314,652 Unrecognized expense at December 31, 2022 $ 1,698,126
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]	Years Ended December 31, 2022 2021 General and administrative $ 262,060 $ 289,782 Sales and marketing 113,838 81,093 Engineering, research, and development 211,712 178,893 $ 587,610 $ 549,768
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Years Ended December 31, 2022 2021 Risk-free interest rate 0.25% to 0.38% 0.42% to 0.58% Expected life (years) 7.00 6.00 Expected dividend yield — — Expected volatility 72.337% to 76.15% 77.36% to 78.21%
Restricted Stock Units (RSUs) [Member]
Notes Tables
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]	Years Ended December 31, 2022 2021 General and administrative $ 260,010 $ 260,005 Sales and Marketing — 187,501 $ 260,010 $ 447,506
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,120,404 Awarded 654,663 $ 1.77 — $ 60,003 Released — $ — — $ — Canceled/forfeited/expired (406,250 ) $ 1.80 — $ — Outstanding at December 31, 2021 1,685,141 $ 1.18 — $ 1,180,407 Awarded 244,792 $ 1.06 — $ 260,579 Released — $ — — $ — Canceled/forfeited/expired — $ — — $ — Outstanding at December 31, 2022 1,929,933 $ 0.75 — $ 1,440,986 Vested at December 31, 2022 1,929,933 $ — — $ 1,865,401 Unvested at December 31, 2022 — $ — — $ — Unrecognized expense at December 31, 2022 $ —

Note 10 - Warrants to Purchas_2

Note 10 - Warrants to Purchase Common Stock (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 Granted 580,231 $ — — Exercised — $ — — Canceled/forfeited/expired (25,000 ) $ — — Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised — $ — — Canceled/forfeited/expired (3,188,190 ) $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27

Note 11 - Income Taxes (Tables)

Note 11 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	2022 2021 Federal – current $ — $ — State – current — — Foreign – current — — Total $ — $ —
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2022 2021 Deferred tax assets (liabilities): Net operating loss carryforwards $ 19,791,000 $ 16,915,000 Stock based compensation 4,781,000 4,372,000 Accrued compensation 231,300 31,000 Depreciation and amortization 3,305,000 3,783,000 Other — 2,000 Total deferred tax assets 28,108,300 25,103,000 Valuation allowance for net deferred tax assets (28,108,300 ) (25,103,000 ) Total $ — $ —
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	2022 2021 Computed expected tax expense $ (2,088,000 ) $ (1,735,000 ) State taxes, net of federal benefit (1,030,000 ) (799,000 ) Expiration of NOL carryforwards (684,000 ) 87,000 Other 101,000 142,000 Change in valuation allowance 3,701,000 1,729,000 Total $ ---- $

Note 12 - Fair Value Measurem_2

Note 12 - Fair Value Measurements of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ — Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,124,720 $ —

Note 1 - Nature of Operations (

Note 1 - Nature of Operations (Details Textual)	12 Months Ended
	Dec. 31, 2022
Average Percent Increase In Guest Spending Using Company Platform	13%
Percent Of Improvement In Frequency Using Company Platform	26%
Minimum [Member]
Number of Stores	40,000

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Accounts Receivable, Allowance for Credit Loss, Current	$ 34,446	$ 56,340
Goodwill, Impairment Loss	411,183	85,169
Impairment of Intangible Assets (Excluding Goodwill), Total	552,476	8,286
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total	(10,109,997)	(8,288,426)
Advertising Expense	377,201	962,049
Marketing Expense	$ 101,044	$ 50,267
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	2 years	2 years
Impairment of Intangible Assets, Finite-Lived	$ 0	$ 0
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	1 year
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	20 years
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers	4	3
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk, Percentage	86%	94%
Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers	2	2
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk, Percentage	51%	55%

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Computation of Net Loss Per Common Share (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Antidilutive securities (in shares)	14,769,047	11,178,297
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	6,691,216	6,246,466
Restricted Stock Units (RSUs) [Member]
Antidilutive securities (in shares)	1,929,933	1,685,141
Warrant [Member]
Antidilutive securities (in shares)	6,147,898	3,246,690

Note 3 - Going Concern (Details

Note 3 - Going Concern (Details Textual) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 28, 2022	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash			$ 426,740	$ 735,424
Net Income (Loss) Attributable to Parent, Total			(10,061,122)	(8,259,784)
Net Cash Provided by (Used in) Operating Activities, Total			(6,688,551)	(4,484,598)
Proceeds from Warrant Exercises	$ 2,600,000
Proceeds from Issuance of Private Placement			2,100,000
Retained Earnings (Accumulated Deficit), Total			$ (117,896,409)	$ (107,835,287)
Subsequent Event [Member]
Proceeds from Warrant Exercises		$ 3,557,487

Note 4 - Goodwill and Intangi_3

Note 4 - Goodwill and Intangible Assets (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill, Impairment Loss	$ 411,183	$ 85,169
Amortization of Intangible Assets	133,010	163,760
Impairment of Intangible Assets (Excluding Goodwill), Total	$ 552,476	$ 8,286

Note 4 - Goodwill and Intangi_4

Note 4 - Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill	$ 411,183	$ 496,352
Acquired	0	0
Impairment	(411,183)	(85,169)
Goodwill	$ 0	$ 411,183

Note 4 - Goodwill and Intangi_5

Note 4 - Goodwill and Intangible Assets - Schedule of Finite Lived Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Patents and Trademarks [Member]
Gross carrying amount	$ 57,595	$ 105,543
Accumulated Amortization	(4,897)	(47,948)
Net carrying amount	$ 52,698	$ 57,595
Finite-Lived Intangible Asset, Useful Life (Year)	14 years	14 years
Customer Relationships [Member]
Gross carrying amount	$ 545,533	$ 2,321,112
Accumulated Amortization	(514,843)	(1,775,579)
Net carrying amount	$ 30,690	$ 545,533
Finite-Lived Intangible Asset, Useful Life (Year)	10 years	10 years
Trade Names [Member]
Gross carrying amount	$ 32,393	$ 197,955
Accumulated Amortization	(24,343)	(165,562)
Net carrying amount	$ 8,050	$ 32,393
Finite-Lived Intangible Asset, Useful Life (Year)	10 years	10 years
Developed Technology Rights [Member]
Gross carrying amount	$ 112,191	$ 621,030
Accumulated Amortization	(112,191)	(508,839)
Net carrying amount	$ 0	$ 112,191
Finite-Lived Intangible Asset, Useful Life (Year)	10 years	10 years
Noncompete Agreements [Member]
Gross carrying amount	$ 29,212	$ 79,300
Accumulated Amortization	(29,212)	(50,088)
Net carrying amount	$ 0	$ 29,212
Finite-Lived Intangible Asset, Useful Life (Year)	2 years	2 years
Intangibles Excluding Capitalized Software [Member]
Gross carrying amount	$ 776,924	$ 3,324,940
Accumulated Amortization	(685,486)	(2,548,016)
Net carrying amount	$ 91,438	$ 776,924

Note 4 - Goodwill and Intangi_6

Note 4 - Goodwill and Intangible Assets - Future Amortization Intangible Assets (Details) - Intangibles Excluding Capitalized Software [Member] - USD ($)	Dec. 31, 2022	Dec. 31, 2021
2022	$ 35,885
2023	12,639
2024	4,891
2025	4,891
2025	4,891
Thereafter	28,241
Total	$ 91,438	$ 776,924

Note 5 - Software Development_3

Note 5 - Software Development Costs (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Capitalized Computer Software, Impairments	$ 13,087	$ 299,253
Amortization of Intangible Assets	$ 133,010	$ 163,760
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	2 years	2 years
Amortization of Intangible Assets	$ 257,548	$ 391,365
Impairment of Intangible Assets, Finite-Lived	$ 0	$ 0

Note 5 - Software Development_4

Note 5 - Software Development Costs - Software Development Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Capitalized Computer Software, Gross	$ 2,578,611	$ 2,565,525
Capitalized Computer Software, Accumulated Amortization	(2,475,277)	(2,217,729)
Capitalized Computer Software, Net, Ending Balance	103,334	347,796
Computer Software, Intangible Asset [Member]
Capitalized Computer Software, Gross	2,578,611	2,565,525
Capitalized Computer Software, Accumulated Amortization	(2,475,277)	(2,217,729)
Capitalized Computer Software, Net, Ending Balance	$ 103,334	$ 347,796
Finite-Lived Intangible Asset, Useful Life (Year)	2 years	2 years

Note 5 - Software Development_5

Note 5 - Software Development Costs - Estimated Future Amortization Expense (Details) - Computer Software, Intangible Asset [Member]	Dec. 31, 2022 USD ($)
2022	$ 98,828
2023	4,506
2024	0
2025	0
Thereafter	0
Total	$ 103,334

Note 6 - Operating Lease Asse_3

Note 6 - Operating Lease Assets (Details Textual)		12 Months Ended
	Feb. 01, 2021 USD ($) ft²	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Operating Lease, Right-of-Use Asset, Amortization Expense		$ 23,599	$ 2,575
Payments for Rent		$ 371,213	$ 258,368
Lease Ending January 2027 [Member]
Area of Real Estate Property (Square Foot) | ft²	8,898
Lease Ending January 2027 [Member] | Minimum [Member]
Monthly Rental Expense	$ 25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Monthly Rental Expense	$ 28,733

Note 6 - Operating Lease Asse_4

Note 6 - Operating Lease Assets - Additional Details Related To Lease (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Operating lease assets	$ 0
Operating lease assets	981,896
Operating lease assets	981,896	$ 1,187,537
Operating lease liability, current	251,665	229,240
Operating lease liabilities	936,924	$ 1,188,589
Total lease liabilities	$ 1,188,589

Note 6 - Operating Lease Asse_5

Note 6 - Operating Lease Assets - Schedule of Minimum Lease Payments (Details)	Dec. 31, 2022 USD ($)
2023	$ 324,221
2024	330,894
2025	337,568
2026	344,241
2027	28,733
Thereafter	0
Total future lease payments	1,365,657
Less: imputed interest	(177,068)
Operating Lease, Liability, Total	$ 1,188,589

Note 6 - Operating Lease Asse_6

Note 6 - Operating Lease Assets - Weight Average Remaining Term and Discount Rate (Details)	Dec. 31, 2022
Weighted Average Remaining Lease Term (years) Operating leases (Year)	4 years 29 days
Weighted Average Discount Rate, Operating leases	6.75%

Note 7 - Notes Payable and In_3

Note 7 - Notes Payable and Interest Expense (Details Textual)																1 Months Ended	3 Months Ended		5 Months Ended	6 Months Ended	12 Months Ended
	Dec. 27, 2022 USD ($)	Nov. 30, 2022 USD ($)	Nov. 22, 2022 USD ($)	Aug. 09, 2022 USD ($)	Aug. 01, 2022 CAD ($)	Jun. 10, 2022 USD ($)	Aug. 01, 2021 CAD ($)	Jul. 21, 2021 USD ($)	Jul. 01, 2021 USD ($) shares	Jun. 30, 2021 USD ($) $ / shares	Apr. 22, 2020 USD ($)	Apr. 10, 2020 USD ($)	Nov. 01, 2019 CAD ($)	Nov. 14, 2018 USD ($)	Nov. 06, 2017 CAD ($)	Mar. 31, 2023 $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2022 CAD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2022 CAD ($) shares	Dec. 31, 2021 USD ($)	Dec. 31, 2021 CAD ($)	Dec. 31, 2020 USD ($)	Nov. 13, 2022 $ / shares	Nov. 11, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($)	Aug. 13, 2022 $ / shares	Feb. 09, 2022 $ / shares	Apr. 22, 2020 CAD ($)
Gain (Loss) on Extinguishment of Debt, Total																					$ 0		$ 891,103
Interest Expense, Debt, Total																					737,745		267,966
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																														$ 0.80
Gain (loss) on Settlement of Debt																					(49,503)		$ 0
Subsequent Event [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																$ 1	$ 1
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Certain Investors Officers and Directors [Member]
Debt Conversion, Original Debt, Amount																					$ 10,352
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																					9,585	9,585
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Subsequent Event [Member] | Certain Investors Officers and Directors [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																2,757
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member]
Debt Conversion, Original Debt, Amount																					$ 151,398
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																					140,185	140,185
Gain (loss) on Settlement of Debt																					$ (2,259)
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Subsequent Event [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																154,106	154,106
Gain (loss) on Settlement of Debt																	$ 44,325
Director [Member] | Warrants To Purchase Common Stock Under Credit Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares										$ 1.67
Warrant Exercisable Period, After Issuance Of Financing (Month)										36 months
Warrant Vesting Period (Year)										3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																		338,708			338,708
Fair Value of Warrants Issued																		$ 143,039			$ 143,039
Acoa Note [Member] | Livelenz [Member]
Debt Instrument, Periodic Payment, Total					$ 4,500		$ 4,000						$ 3,500		$ 3,000				$ 2,215			$ 45,052		$ 10,485
Wintrust Loan [Member]
Debt Instrument, Periodic Payment, Total														$ 33,333											$ 400,000
Debt Instrument, Face Amount														$ 1,000,000
Debt Instrument, Term (Year)														3 years
Proceeds from Loan Refinance														$ 1,000,000
Wintrust Loan [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate														1.50%
Chase Loan [Member]
Debt Instrument, Face Amount												$ 891,103
Debt Instrument, Term (Year)												2 years
Debt Instrument, Interest Rate, Stated Percentage												1%
Gain (Loss) on Extinguishment of Debt, Total								$ 891,103
TD Bank [Member]
Debt Instrument, Periodic Payment, Total											$ 0
Debt Instrument, Face Amount																															$ 40,000
Debt Instrument, Interest Rate, Stated Percentage																															0%
Percent of Loan Forgiven											33%
Percent of Loan Repaid Requirement for Forgiveness											67%
Credit Agreement [Member] | Director [Member]
Debt Instrument, Interest Rate, Stated Percentage										15%																	15%
Line of Credit Facility, Maximum Borrowing Capacity										$ 6,000,000																	$ 6,000,000	$ 6,000,000
Proceeds from Long-Term Lines of Credit Including Interest																				$ 3,478,125	5,173,125
Proceeds from Long-Term Lines of Credit	$ 470,000	$ 250,000	$ 375,000	$ 300,000		$ 500,000														3,206,250
Interest Expense, Debt, Total																		166,432		271,875
Repayments of Long-Term Lines of Credit																				$ 200,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares										$ 1.67
Warrant Exercisable Period, After Issuance Of Financing (Month)										36 months
Credit Facility Fee, Numerator										20%
Credit Facility Fee, Denominator Measurement Period (Day)										30 days
Warrant Vesting Period (Year)										3 years
Debt Instrument, Number Of Monthly Installments										24
Interest Payable																		387,918			387,918
Gain (loss) on Settlement of Debt																					(2,259)
Debt Instrument, Monthly Conversion of Interest, Rate Per Share (in dollars per share) | $ / shares																										$ 24
Credit Agreement [Member] | Director [Member] | Common Stock Issued to Settle Accrued Interest [Member]
Share Price (in dollars per share) | $ / shares																											$ 1.08
Unsecured Notes Issued July, 1, 2021 [Member] | Certain Investors Officers and Directors [Member]
Interest Expense, Debt, Total																		9,651
Interest Payable																		55,530			55,530
Gain (loss) on Settlement of Debt																					(162)
Debt Instrument, Prepayment Penalty									2%
Payments for Commissions									$ 0
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares) | shares									33,017
Debt Instrument, Monthly Conversion of Interest, Rate Per Share (in dollars per share) | $ / shares																													$ 24
Long-Term Debt, Gross																		271,875			271,875
Unsecured Notes Issued July, 1, 2021 [Member] | Certain Investors Officers and Directors [Member]
Debt Instrument, Face Amount									$ 271,875
Debt Instrument, Interest Rate, Stated Percentage									15%
Interest Payable																		55,530			55,530
Debt Conversion, Original Debt, Amount																					$ 10,352
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																					9,585	9,585
Gain (loss) on Settlement of Debt																					$ (162)
Debt Instrument, Prepayment Penalty									2%
Payments for Commissions									$ 0
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares) | shares									33,017
Long-Term Debt, Gross																		$ 271,875			$ 271,875
Unsecured Notes Issued July, 1, 2021 [Member] | Certain Investors Officers and Directors [Member] | Subsequent Event [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																	9,651
Gain (loss) on Settlement of Debt																	$ 2,757

Note 7 - Notes Payable and In_4

Note 7 - Notes Payable and Interest Expense - Schedule of Notes Payable (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Apr. 22, 2020
Debt and Lease Obligation, Total	$ 5,256,170	$ 3,426,380
Less current portion	(2,743,788)	(888,583)
Long-term debt, net of current portion	2,512,382	2,537,797
Acoa Note [Member]
Debt and Lease Obligation, Total	34,231	76,642
TD Bank [Member]
Debt and Lease Obligation, Total	29,478	31,496
Debt Instrument Interest Rate Stated Percentage			0%
Related Party Note [Member]
Debt and Lease Obligation, Total	$ 5,192,461	$ 3,318,242
Debt Instrument Interest Rate Stated Percentage	15%

Note 7 - Notes Payable and In_5

Note 7 - Notes Payable and Interest Expense - Schedule of Maturities (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
2023	$ 2,743,788
2024	2,497,643
2025	14,739
2026	0
2027	0
Thereafter	0
Total future debt payments	$ 5,256,170	$ 3,426,380

Note 7 - Notes Payable and In_6

Note 7 - Notes Payable and Interest Expense - Summary of Interest Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Interest expense	$ 737,745	$ 267,966
Total interest expense	$ 737,745	$ 267,966

Note 8 - Common Stock and Equ_2

Note 8 - Common Stock and Equity Payable (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement, Expense	$ 1,457,570
Equity Amount Payable	324,799	$ 100,862
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense	$ 260,010	$ 447,506
Restricted Stock Units (RSUs) [Member] | Board Of Directors [Member]
Stock Issued During Period, Shares, New Issues (in shares)	5,900,460	0
Share-Based Payment Arrangement, Expense	$ 260,010	$ 260,005
Restricted Stock Units (RSUs) [Member] | Employees [Member]
Share-Based Payment Arrangement, Expense	$ 0	$ 187,501

Note 9 - Stock-based Plans an_3

Note 9 - Stock-based Plans and Stock-based Compensation (Details Textual)												3 Months Ended		12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 14, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 22, 2022 USD ($) $ / shares shares	May 16, 2022 USD ($) $ / shares shares	Mar. 29, 2022 USD ($) $ / shares shares	Dec. 15, 2021 USD ($) $ / shares shares	Aug. 11, 2021 USD ($) $ / shares shares	May 17, 2021 USD ($) $ / shares shares	May 12, 2021 $ / shares shares	Mar. 26, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | shares	14,769,047													14,769,047
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) | shares	22,585,015													22,585,015
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		36 months		36 months	36 months	36 months	48 years	48 years	48 years		48 years
Options To Purchase Shares Inthemoney (in shares) | shares	4,057,500													4,057,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares														$ 0.99	$ 0.79
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares		180,000		1,000,000	45,000	150,000	545,000	5,000	20,000		67,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares		$ 1.44		$ 0.98	$ 0.97	$ 0.8289	$ 1.53	$ 1.53	$ 1.67		$ 1.80
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		75.76%		76.15%	73.45%	72.33%	71.53%	73.29%	74.79%		73.97%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value (in dollars per share) | $ / shares		$ 1.039857		$ 0.697499	$ 0.642608	$ 0.54	$ 0.97	$ 1.12	$ 0.93		$ 1.16
Share-Based Compensation Arrangement by Share-Based Payment Award, Call Option Value		$ 187,174		$ 697,499	$ 28,917	$ 81,035	$ 528,434	$ 5,606	$ 18,628		$ 78,492
Number of Employees, Awards Granted		1		1	3	1	19	1	1
Share-Based Payment Arrangement, Expense														$ 1,457,570
Deferred Compensation Equity	$ 1,527,647													$ 1,527,647
Vesting on the First Anniversary [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		25%		25%	25%	25%
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)														4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)														10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares														1,375,000	637,500
Share-Based Payment Arrangement, Expense														$ 587,610	$ 549,768
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense														260,010	447,506
Salary and Wage, Officer, Excluding Cost of Good and Service Sold														260,010	447,506
Restricted Stock Units (RSUs) [Member] | Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)											4 years
Share-Based Payment Arrangement, Expense														0	187,501
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares											500,000
Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Value											$ 900,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share (in dollars per share) | $ / shares											$ 1.80
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) | shares											114,583
Restricted Stock Units (RSUs) [Member] | Board Of Directors [Member]
Number of Employees, Awards Granted	4		4		4	4	4	4		4
Share-Based Payment Arrangement, Expense														260,010	$ 260,005
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares	47,104		65,100		54,168	78,420	42,484	37,144		38,924	36,112
Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Value	$ 65,004		$ 65,002		$ 65,002	$ 65,002	$ 65,000				$ 65,000	$ 65,000	$ 65,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share (in dollars per share) | $ / shares	$ 1.38		$ 0.9985		$ 1.20	$ 0.829	$ 1.53	$ 1.75		$ 1.67	$ 1.80
Investor Warrant [Member]
Share-Based Payment Arrangement, Expense														$ 609,950

Note 9 - Stock-based Plans an_4

Note 9 - Stock-based Plans and Stock-based Compensation - Stock Options Activity (Details) - USD ($)									12 Months Ended
	Dec. 14, 2022	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Dec. 15, 2021	Aug. 11, 2021	May 17, 2021	Mar. 26, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Granted, shares (in shares)	180,000	1,000,000	45,000	150,000	545,000	5,000	20,000	67,500
Share-Based Payment Arrangement, Option [Member]
Balance (in shares)									6,246,466	6,007,552
Balance, exercise price (in dollars per share)									$ 1.20	$ 1.20
Balance, contractual term (Year)									5 years 10 months 9 days	7 years 2 months 1 day	6 years 9 months 7 days
Balance, aggregate intrinsic value									$ 2,086,829	$ 4,056,639	$ 527,868
Granted, shares (in shares)									1,375,000	637,500
Granted, exercise price (in dollars per share)									$ 1.02	$ 1.56
Exercised, shares (in shares)									0	0
Exercised, exercise price (in dollars per share)									$ 0	$ 1.61
Forfeit/canceled, shares (in shares)									(330,623)	(272,029)
Forfeit/canceled, exercise price (in dollars per share)									$ 1.09	$ 2.18
Expired, shares (in shares)									(599,627)	(126,557)
Expired, exercise price (in dollars per share)									$ 0.98	$ 1.17
Exercised, shares (in shares)									0	0
Balance, shares (in shares)									6,691,216	6,246,466	6,007,552
Balance, exercise price (in dollars per share)									$ 1.19	$ 1.20	$ 1.20
Expected to vest at End of Period (in shares)									6,691,216
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)									$ 1.19
Expected, Weighted Average Remaining Contractual Term (Years) (Year)									5 years 10 months 6 days
Share-Based Compensation Arrangement By Share-Based Payment Award Options Vested And Expected To Vest Aggregate Intrinsic Value									$ 2,086,829
Exercisable at End of Period (in shares)									3,987,966
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in dollars per share)									$ 1.22
Exercisable, Weighted Average Remaining Contractual Term (Years) (Year)									3 years 11 months 23 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value									$ 1,314,652
Unrecognized expense at End of Period									$ 1,698,126

Note 9 - Stock-based Plans an_5

Note 9 - Stock-based Plans and Stock-based Compensation - Schedule of Compensation Costs by Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Stock-based compensation expense	$ 1,457,570
Share-Based Payment Arrangement, Option [Member]
Stock-based compensation expense	587,610	$ 549,768
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]
Stock-based compensation expense	262,060	289,782
Share-Based Payment Arrangement, Option [Member] | Selling and Marketing Expense [Member]
Stock-based compensation expense	113,838	81,093
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]
Stock-based compensation expense	$ 211,712	$ 178,893

Note 9 - Stock-based Plans an_6

Note 9 - Stock-based Plans and Stock-based Compensation - Valuation Assumptions (Details)									12 Months Ended
	Dec. 14, 2022	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Dec. 15, 2021	Aug. 11, 2021	May 17, 2021	Mar. 26, 2021	Dec. 31, 2022	Dec. 31, 2021
Expected life (years) (Year)									7 years	6 years
Expected dividend yield									0%	0%
Expected volatility	75.76%	76.15%	73.45%	72.33%	71.53%	73.29%	74.79%	73.97%
Minimum [Member]
Risk-free interest rate									0.25%	0.42%
Expected volatility									72.337%	77.36%
Maximum [Member]
Risk-free interest rate									0.38%	0.58%
Expected volatility									76.15%	78.21%

Note 9 - Stock-based Plans an_7

Note 9 - Stock-based Plans and Stock-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Balance, shares (in shares)	1,685,141	1,436,728
Balance, exercise price (in dollars per share)	$ 1.18	$ 0.86
Balance, aggregate intrinsic value	$ 1,440,986	$ 1,180,407	$ 1,120,404
Awarded, shares (in shares)	244,792	654,663
Awarded, exercise price (in dollars per share)	$ 1.06	$ 1.77
Awarded, aggregate intrinsic value	$ 260,579	$ 60,003
Released, shares (in shares)	0	0
Canceled/forfeited/expired, shares (in shares)	0	(406,250)
Canceled/forfeited/expired, exercise price (in dollars per share)	$ 0	$ 1.80
Canceled/forfeited/expired, aggregate intrinsic value	$ 0	$ 0
Balance, shares (in shares)	1,929,933	1,685,141
Balance, exercise price (in dollars per share)	$ 0.75	$ 1.18
Vested, shares (in shares)	1,929,933
Vested, exercise price (in dollars per share)	$ 0
Vested, aggregate intrinsic value	$ 1,865,401
Unvested, shares (in shares)	0
Unrecognized expense	$ 0

Note 9 - Stock-based Plans an_8

Note 9 - Stock-based Plans and Stock-based Compensation - Restricted Stock Compensation Cost Allocation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Stock-based compensation expense	$ 1,457,570
Restricted Stock Units (RSUs) [Member]
Stock-based compensation expense	260,010	$ 447,506
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]
Stock-based compensation expense	260,010	260,005
Restricted Stock Units (RSUs) [Member] | Selling and Marketing Expense [Member]
Stock-based compensation expense	$ 0	$ 187,501

Note 10 - Warrants to Purchas_3

Note 10 - Warrants to Purchase Common Stock (Details Textual)						12 Months Ended
	Aug. 24, 2022 USD ($) $ / shares shares	Jun. 29, 2022 USD ($) $ / shares shares	Feb. 09, 2022 USD ($) $ / shares shares	Aug. 11, 2021 USD ($) shares	Jun. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2021 $ / shares shares
Share-Based Payment Arrangement, Expense						$ 1,457,570
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 0.80
Number of Warrant Holders That Exercised Warrants			17
Stock Issued During Period, Shares, Warrant Exercise (in shares) | shares			3,188,190
Stock Issued During Period Value, Warrant Exercise			$ 2,550,553
Warrant Issuance Four [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares					227,994			238,066
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares					$ 1.67
Warrants and Rights Outstanding					$ 119,103
Warrant Exercisable Period, After Issuance Of Financing (Month)					36 months
Warrant Issuance Four Exercise Price [Member]
Warrants and Rights Outstanding					$ 119,760
Warrant Issuance Four Volume Weighted Average Price [Member]
Warrants and Rights Outstanding					$ 108,234
Warrant Issuance Five [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares				10,072
Warrants and Rights Outstanding				$ 5,285
Warrant Exercisable Period, After Issuance Of Financing (Month)				36 years
Warrant Issuance Three [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares								2,666,459
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares								$ 2.06
Inducement Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares			3,188,190
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 1.50	$ 1.50	$ 1.50
Stock Issued During Period, Shares, Warrant Exercise (in shares) | shares	1,500,000	1,062,500
Warrants and Rights Outstanding, Term (Year)	3 years	3 years	3 years
Warrant Issuance [Member]
Share-Based Payment Arrangement, Expense			$ 609,950
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 0.80	$ 0.80
Stock Issued During Period, Shares, Warrant Exercise (in shares) | shares	1,500,000	1,062,500
Stock Issued During Period Value, Warrant Exercise	$ 1,200,000	$ 850,000
Warrant Issuance [Member]
Share-Based Payment Arrangement, Expense							$ 0

Note 10 - Warrants to Purchas_4

Note 10 - Warrants to Purchase Common Stock - Summary of Investor Warrant Activity (Details) - $ / shares									12 Months Ended
	Dec. 14, 2022	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Dec. 15, 2021	Aug. 11, 2021	May 17, 2021	Mar. 26, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Granted, shares (in shares)	180,000	1,000,000	45,000	150,000	545,000	5,000	20,000	67,500
Investor Warrant [Member]
Balance (in shares)									3,246,690	2,691,459
Balance, exercise price (in dollars per share)									$ 2.26	$ 1.99
Balance, term (in dollars per share)									$ 2.27	$ 3.59	$ 2.94
Granted, shares (in shares)									6,089,398	580,231
Granted, exercise price (in dollars per share)									$ 0	$ 0
Exercised, shares (in shares)									0	0
Canceled/forfeited/expired, shares (in shares)									(3,188,190)	(25,000)
Canceled/forfeited/expired, exercise price (in dollars per share)									$ 0	$ 0
Balance, shares (in shares)									6,147,898	3,246,690	2,691,459
Balance, exercise price (in dollars per share)									$ 1.45	$ 2.26	$ 1.99

Note 11 - Income Taxes (Details

Note 11 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 2,479,000	$ 568,000
Operating Loss Carryforwards	64,000,000
Change in ownership limit, operating loss	207,000
Pre change net operating loss carryforward	6,000,000
Liability for Uncertainty in Income Taxes, Current	0
Income Tax Examination, Penalties and Interest Accrued, Total	0
State and Local Jurisdiction [Member]
Operating Loss Carryforwards	$ 61,000,000
State and Local Jurisdiction [Member] | Earliest Tax Year [Member]
Open Tax Year	2006

Note 11 - Income Taxes - Compon

Note 11 - Income Taxes - Components of Income Tax Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Federal – current	$ 0	$ 0
State – current	0	0
Foreign – current	0	0
Total	$ 0	$ 0

Note 11 - Income Taxes - Schedu

Note 11 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Net operating loss carryforwards	$ 19,791,000	$ 16,915,000
Stock based compensation	4,781,000	4,372,000
Accrued compensation	231,300	31,000
Tax asset depreciation and amortization	3,305,000	3,783,000
Other tax assets	0	2,000
Total deferred tax assets	28,108,300	25,103,000
Valuation allowance for net deferred tax assets	(28,108,300)	(25,103,000)
Total	$ 0	$ 0

Note 11 - Income Taxes - Income

Note 11 - Income Taxes - Income Tax Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Computed expected tax expense	$ (2,088,000)	$ (1,735,000)
State taxes, net of federal benefit	(1,030,000)	(799,000)
Expiration of NOL carryforwards	(684,000)	87,000
Other	101,000	142,000
Change in valuation allowance	$ 3,701,000	$ 1,729,000

Note 12 - Fair Value Measurem_3

Note 12 - Fair Value Measurements of Financial Instruments- Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Nonrecurring [Member] - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Inputs, Level 1 [Member]
Goodwill (non-recurring)	$ 0	$ 0
Intangibles, net (non-recurring)	0	0
Fair Value, Inputs, Level 2 [Member]
Goodwill (non-recurring)	0	0
Intangibles, net (non-recurring)	0	0
Fair Value, Inputs, Level 3 [Member]
Goodwill (non-recurring)	0	411,183
Intangibles, net (non-recurring)	$ 194,772	$ 1,124,720

Note 13 - Commitments and Con_2

Note 13 - Commitments and Contingencies (Details Textual)			12 Months Ended
	Apr. 01, 2022 USD ($) ft²	Feb. 01, 2021 USD ($) ft²	Dec. 31, 2022 USD ($) ft²	Dec. 31, 2021 USD ($)
Loss Contingency, Claims Settled, Number			3
Gain (Loss) Related to Litigation Settlement			$ (53,500)
Operating Lease, Right-of-Use Asset			981,896	$ 1,187,537
Operating Lease, Liability, Total			$ 1,188,589
Lease Ending January 2021 [Member]
Area of Real Estate Property (Square Foot) | ft²			10,395
Monthly Rental Expense			$ 20,140
Operating Lease, Right-of-Use Asset			0
Operating Lease, Liability, Total			0
Lease Ending January 2027 [Member]
Area of Real Estate Property (Square Foot) | ft²		8,898
Operating Lease, Right-of-Use Asset			1,177,094
Operating Lease, Liability, Total			1,404,533
Lessee, Operating Lease, Abatement Percentage		50%
Lease Ending January 2027 [Member] | Minimum [Member]
Monthly Rental Expense		$ 25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Monthly Rental Expense		$ 28,733
Lease Ending April 2022 [Member]
Monthly Rental Expense	$ 3,371
Operating Lease, Right-of-Use Asset			10,443
Operating Lease, Liability, Total			$ 13,296
Lease area of office (Square Foot) | ft²	3,248

Note 14 - Employee Benefit Pl_2

Note 14 - Employee Benefit Plan (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 0	$ 0

Note 15 - Related Party Trans_2

Note 15 - Related Party Transactions (Details Textual) - USD ($)										1 Months Ended		3 Months Ended		6 Months Ended	12 Months Ended
	Dec. 27, 2022	Nov. 30, 2022	Nov. 22, 2022	Aug. 24, 2022	Aug. 09, 2022	Jun. 10, 2022	Feb. 07, 2022	Jul. 01, 2021	Jun. 30, 2021	Mar. 31, 2023	Feb. 28, 2022	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Nov. 13, 2022	Nov. 11, 2022	Sep. 30, 2022	Jun. 29, 2022	Feb. 09, 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																					$ 0.80
Gain (loss) on Settlement of Debt															$ (49,503)	$ 0
Interest Expense, Total															737,745	267,966
Proceeds from Warrant Exercises											$ 2,600,000
Proceeds from Issuance of Common Stock															2,050,000	0
Former Director [Member]
Stock Issued During Period, Shares, New Issues (in shares)				625,000
Shares Issued, Price Per Share (in dollars per share)				$ 0.80
Proceeds from Issuance of Common Stock				$ 500,000
Subsequent Event [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)										$ 1		$ 1
Proceeds from Warrant Exercises												$ 3,557,487
Inducement Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 1.50																$ 1.50	$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																					3,188,190
Warrants and Rights Outstanding, Term (Year)				3 years																3 years	3 years
Inducement Warrant [Member] | Subsequent Event [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)										$ 2		$ 2
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)										1,793,745		1,793,745
Warrants and Rights Outstanding, Term (Year)										3 years		3 years
Warrant to Former Director [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				625,000
Warrants and Rights Outstanding, Term (Year)				3 years
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member]
Debt Conversion, Original Debt, Amount															$ 151,398
Debt Conversion, Converted Instrument, Shares Issued (in shares)															140,185
Gain (loss) on Settlement of Debt															$ (2,259)
Interest Expense, Total													$ 166,432
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Subsequent Event [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)										154,106		154,106
Gain (loss) on Settlement of Debt												$ 44,325
Director [Member] | Warrants To Purchase Common Stock Under Credit Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)									$ 1.67
Warrant Exercisable Period, After Issuance Of Financing (Month)									36 months
Warrant Vesting Period (Year)									3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)													338,708		338,708
Warrants and Rights Outstanding													$ 143,039		$ 143,039
Director [Member] | Common Stock Purchase Warrants [Member]
Class of Warrant or Right, Exercised During Period (in shares)							1,604,389
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)							$ 0.80
Proceeds from Warrant Exercises							$ 1,283,518
Director [Member] | Inducement Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)							$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)							1,604,398
Warrants and Rights Outstanding, Term (Year)							3 years
Director [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity									$ 6,000,000									$ 6,000,000	$ 6,000,000
Long-Term Line of Credit, Total														$ 3,478,125		$ 3,478,125
Proceeds from Long-Term Lines of Credit	$ 470,000	$ 250,000	$ 375,000		$ 300,000	$ 500,000								3,206,250
Line Of Credit Facility, Increase From Conversion Of Notes Payable														271,875
Repayments of Long-Term Lines of Credit														200,000
Debt Instrument, Interest Rate, Stated Percentage									15%									15%
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)									$ 1.67
Warrant Exercisable Period, After Issuance Of Financing (Month)									36 months
Credit Facility Fee, Numerator									20%
Credit Facility Fee, Denominator Measurement Period (Day)									30 days
Warrant Vesting Period (Year)									3 years
Debt Instrument, Number Of Monthly Installments									24
Debt Instrument, Convertible, Conversion Price (in dollars per share)																		$ 1.08
Proceeds from Long-Term Lines of Credit Including Interest														$ 3,478,125	5,173,125
Interest Payable													387,918		387,918
Gain (loss) on Settlement of Debt															(2,259)
Debt Instrument, Monthly Conversion of Interest, Rate Per Share (in dollars per share)																	$ 24
Certain Investors Officers and Directors [Member] | Unsecured Notes Issued July, 1, 2021 [Member]
Debt Instrument, Interest Rate, Stated Percentage								15%
Interest Payable													55,530		55,530
Debt Conversion, Original Debt, Amount															$ 10,352
Debt Conversion, Converted Instrument, Shares Issued (in shares)															9,585
Gain (loss) on Settlement of Debt															$ (162)
Interest Expense, Total													10,423
Debt Instrument, Face Amount								$ 271,875
Debt Instrument, Prepayment Penalty								2%
Payments for Commissions								$ 0
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)								33,017
Long-Term Debt, Gross													$ 271,875		$ 271,875
Certain Investors Officers and Directors [Member] | Unsecured Notes Issued July, 1, 2021 [Member] | Subsequent Event [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)												9,651
Gain (loss) on Settlement of Debt												$ 2,757
Talkot Fund LP [Member] | Common Stock Purchase Warrants [Member]
Class of Warrant or Right, Exercised During Period (in shares)							517,292
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)							$ 0.80
Proceeds from Warrant Exercises							$ 413,834
Talkot Fund LP [Member] | Inducement Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)							$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)							517,292
Warrants and Rights Outstanding, Term (Year)							3 years

Note 16 - Subsequent Events (De

Note 16 - Subsequent Events (Details Textual) - USD ($)						1 Months Ended	3 Months Ended
	Mar. 27, 2023	Jan. 31, 2023	Aug. 24, 2022	Jun. 29, 2022	Feb. 09, 2022	Feb. 28, 2022	Mar. 31, 2023	Feb. 07, 2022
Stock Issued During Period, Shares, Warrant Exercise (in shares)					3,188,190
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 0.80
Proceeds from Warrant Exercises						$ 2,600,000
Inducement Warrant [Member]
Stock Issued During Period, Shares, Warrant Exercise (in shares)			1,500,000	1,062,500
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)			$ 1.50	$ 1.50	$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					3,188,190
Warrants and Rights Outstanding, Term (Year)			3 years	3 years	3 years
Inducement Warrant [Member] | Director [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)								$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)								1,604,398
Warrants and Rights Outstanding, Term (Year)								3 years
Inducement Warrant [Member] | Talkot Fund LP [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)								$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)								517,292
Warrants and Rights Outstanding, Term (Year)								3 years
Subsequent Event [Member]
Stock Issued During Period, Shares, Warrant Exercise (in shares)							3,587,487
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)							$ 1
Proceeds from Warrant Exercises							$ 3,557,487
Subsequent Event [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Director [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)	154,106
Subsequent Event [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Talkot Fund LP [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)	9,651
Subsequent Event [Member] | Former Director [Member]
Stock Issued During Period, Shares, Issued for Services (in shares)		545,012
Subsequent Event [Member] | Inducement Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)							$ 2
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)							1,793,745
Warrants and Rights Outstanding, Term (Year)							3 years